BNP Paribas Arbitrage SA reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 69.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,329 shares of the medical instruments supplier’s stock after selling 222,038 shares during the period. BNP Paribas Arbitrage SA’s holdings in DENTSPLY SIRONA were worth $5,542,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in XRAY. Cooke & Bieler LP acquired a new stake in DENTSPLY SIRONA during the third quarter worth about $149,306,000. Ceredex Value Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 147.6% in the fourth quarter. Ceredex Value Advisors LLC now owns 3,231,363 shares of the medical instruments supplier’s stock valued at $180,631,000 after purchasing an additional 1,926,113 shares during the period. BlackRock Inc. boosted its stake in shares of DENTSPLY SIRONA by 7.0% in the third quarter. BlackRock Inc. now owns 16,991,458 shares of the medical instruments supplier’s stock valued at $986,354,000 after purchasing an additional 1,109,283 shares during the period. Allspring Global Investments Holdings LLC purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $43,683,000. Finally, Two Sigma Advisers LP boosted its stake in shares of DENTSPLY SIRONA by 164.1% in the third quarter. Two Sigma Advisers LP now owns 874,925 shares of the medical instruments supplier’s stock valued at $50,789,000 after purchasing an additional 543,700 shares during the period. Hedge funds and other institutional investors own 94.79% of the company’s stock.
Shares of DENTSPLY SIRONA stock opened at $38.23 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $35.00 and a 52-week high of $69.07. The company has a 50 day moving average of $45.95 and a 200 day moving average of $51.34. The company has a quick ratio of 1.12, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $8.24 billion, a P/E ratio of 22.62, a P/E/G ratio of 2.37 and a beta of 0.94.
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 8th. Shareholders of record on Friday, March 25th were issued a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, March 24th. This represents a $0.50 dividend on an annualized basis and a yield of 1.31%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 29.59%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction that occurred on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total transaction of $273,999.00. Following the sale, the director now owns 35,155 shares of the company’s stock, valued at $1,396,005.05. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.69% of the stock is currently owned by company insiders.
Several research firms have recently commented on XRAY. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday. HC Wainwright lowered their price objective on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a research note on Friday, April 22nd. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and lowered their price objective for the company from $67.00 to $48.00 in a research note on Tuesday, April 19th. Credit Suisse Group lowered their price objective on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating for the company in a research note on Tuesday, March 1st. Finally, William Blair lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 19th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $52.89.
DENTSPLY SIRONA Profile (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.